Individualizing Care for Patients with Hemophilia: Evidence-Based Strategies for Optimizing Adherence and Outcomes
Released On
March 31, 2024
Expires On
March 31, 2025
Media Type
Internet
Completion Time
60 minutes
Specialty
Hematology-Oncology, Pediatrics
Topic(s)
Hemophilia
This activity is jointly provided by Medical Education Resources and Enquiring Minds, LLC
This activity is supported by an educational grant from Sanofi Genzyme.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — maximum of 1.0 nursing contact hour
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of physicians, nurses and other healthcare professionals involved in the care of hemophilia.
Program Overview
Challenge yourself as you individualize treatment plans and assess expert guidance for 3 patients with hemophilia.
Topics addressed may include:
- Treatment paradigms and clinical practice guidelines
- Clinical and patient-centered considerations that guide decision-making
- Best practices for tailoring treatment plans
- Optimizing and assessing clinical response
Learning Objectives
Upon completion of this activity, participants should be able to:
- Tailor evidence-based prophylactic treatment plans with the goal optimizing adherence and clinical outcomes
- Summarize clinical evidence supporting current best practices and evolving treatment options aimed at achieving optimal clinical response in adults with hemophilia
- Assess newly approved and emerging non-factor treatment options for the management of hemophilia and implement them into appropriate individualized management strategies
- Employ patient-centered strategies to identify and overcome disease management challenges.
Faculty
Lisa Boggio, MD, MS
Director, Rush Hemophilia and Thrombophilia Center
Associate Professor, Department of Pediatrics
Rush University
Chicago, IL
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Enquiring Minds, LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare
Credit Designation
Physician Credit Designation Statement
Medical Education Resources designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
Medical Education Resources designates this enduring material for a maximum of 1 ANCC nursing contact hours.
Disclosures of Conflicts of Interest
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
The faculty reported the following relevant financial relationships with ineligible companies whose products or services may be mentioned in this activity:
- Lisa Boggio, MD, MS
- Research Support: Bayer, Sanofi, Novo Nordisk, Octapharma, Genentech, ApcinteX, Regeneron
- Consulting Fees: Sanofi, Alnylam, OctaPharma, Novo Nordisk, Genentech, Kedrion
The planners at Medical Education Resources and Enquiring Minds, LLC have no relevant financial relationships to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving credit for this enduring activity. During the period March 31, 2024 through March 31, 2025, participants must:
- Read the learning objectives and faculty disclosures
- Participate in the online activity
- Complete the evaluation form
A statement of credit will be issued only upon receipt of a completed activity evaluation form. Certificates will be emailed to the participant.
Course Viewing Requirements
Hardware/Software Requirements
This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers (Desktop/Mobile)
Windows: Microsoft Edge (latest version), Google Chrome (latest version), Firefox (latest version)
Mac: Safari (latest version), Google Chrome (latest version), Firefox (latest version)
Mobile: Safari in Apple iOS/iPadOS (latest version), Google Chrome (latest version) in Apple iOS/iPadOS (latest version), Google Chrome (latest version) in Android OS 6 or later
Required Browser Settings
JavaScript: Must be enabled
Font Downloads: Must be enabled
No Compatibility View when using Internet Explorer
Accessibility
Screen readers: NVDA (latest version), JAWS (latest version)
Mac, Apple iOS, Apple iPadOS: VoiceOver
Android OS TalkBack (latest version)
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Enquiring Minds, LLC,and/or Sanofi Genzyme. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Contact Information
For CME questions please contact: 800-421-3756.
Privacy Policy http://cmepartner.org/privacy.
Medical Education Resources and Enquiring Minds, LLC maintain high standards for the protection of privacy over the Internet. The purpose of this statement is to explain what information we obtain, how it is used, and how visitors can restrict its use or disclosure.